The aim of the present study was to evaluate the effect of atorvastatin on some oxidative markers in testes of streptozotocin (STZ) 
INTRODUCTION
Diabetes mellitus (DM) is one of the most common metabolic diseases which is commonly associated with impairment of testicular functions, ultimately leading to reduced fertility in men and animal models (1,2) . The exact pathophysiology mechanism of altered male reproductive function in diabetics remains obscure. However, enhanced oxidative stress and changes in antioxidant capacity could be considered to play a role in the pathogenesis of chronic diabetic complications (2,3) . Multiple biochemical mechanisms have been proposed to increase oxidative stress in diabetes. Among these mechanisms, xanthine oxidase (XO) and the reduced form of nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase) enzymes have been known to produce reactive oxygen species (ROS) and contribute to oxidative stress (4,5) . Xanthine oxidase (XO; EC 1.17.3.2) is implicated in the control of various redox reactions in the cells especially for purine metabolism with hydrogen peroxide (H 2 O 2 ) production. Under some conditions, the product may be superoxide anion (O - ) rather than H 2 O 2 . Xanthine oxidoreductase group has 2 distinct forms; a constitutively expressed form xanthine dehydrogenase, and a posttranscriptional modified form originated by spontaneous proteolytic cleavage consisting of four discrete fragments, the main one is xanthine oxidase (6) . The conversion of dehydrogenase to oxidase occurs in tissue injury (7 ) . NADPH oxidases (NOX; EC 1.6.3.1) are professional superoxideproducing enzymes. The best studied among them is phagocyte NADPH oxidase which consists of a dimmer of a transmembrane subunit gp91 phox , p22 phox , and four cytosolic subunits of p67 phox , p47 phox , p40 phox and rac-2 (8) . When NADPH oxidase is activated, it transports electrons from intracellular NADPH to extracellular oxygen resulting in O - generation which then reacts with proton to form H 2 O 2 . The NOX family consists of 7 members. In testis, NOX 5 iso-enzyme is highly expressed which contains an Nterminal extension with three EF hand motifs and is able to produce O - and to conduct hydrogen ion in response to cytosolic free calcium elevations. So, it might have a function in spermatogenesis and sperm biology (9 ) . ROS generated endogenously or in response to stress have long been implicated in tissue injury and may cause cell death. Cells have evolved numerous survival pathways which include activation of stress-related protein response. Among these, is the hemeoxygenase-1 system (HO-1). Hemeoxygenase (HO; EC 1.14.99.3) is the rate-limiting step in the heme degradation to form biliverdin and carbon monoxide (CO). To date, three identified HO isoforms are part of HO system. These are inducible HO-1 or heat shock protein-32 (HSP-32), constitutive HO-2 and -3. HO-1 and -2 were detected in rat testis. HO-1 have a modulatory role in spermatogenesis under conditions of stress (10) . Co enzyme Q (CoQ) is a highly lipophilic compound which is widely distributed in cell membranes especially inner mitochondrial membrane. CoQ has a dual function as it is essential for production of cellular energy and can act as antioxidant by different mechanisms (11,12) . Mitochondria can contribute to the development of chronic diabetes mellitus because they generate a great amount of ROS. This could stimulate its complications especially in testis since reproductive function is heavily dependent on the energy generated by mitochondria (11 ) . Atorvastatin is a second generation synthetic 3-Hydroxy-3-methyl-glutaryl CoA (HMG-CoA) reductase inhibitor used to treat hypercholesterolemia especially in diabetics with controversial effects on glycemic control and gonadal steroidogenesis (13, 14 ) . The list of different pleiotropic effects of statins is still growing which includes either cholesterol-dependent or-independent effects (15,16) .
AIM OF THE WORK
The aim of the present study was to evaluate the role of some ROSgenerating enzymes (xanthine oxidase and NADPH oxidase) and some endogenous antioxidants (HO-1 and CoQ10) in testes of streptozotocininduced chronic diabetic rats. In addition, it aimed to clarify whether atorvastatin can protect the testes of diabetic rats against oxidative stress.
METHODS

Chemicals:
All chemicals were purchased from Sigma-Aldrich Co. (St Louis, USA). Solvents were of HPLC grade.
Animals: The present study was conducted on 40 adult male albino rats (150-200 gm body weight). The rats were housed under the same environmental conditions, five animals per cage, and given free access to normal laboratory diet and water. All procedures conformed to the guidelines for the care and handling of animals. Only 30 rats remained alive and were classified into three groups: Group I (Control group): included 10 normal rats received single intraperitonial (i.p.) injection of citrate buffer (vehicle buffer). Group II (Diabetic group): included 10 diabetic rats. DM was induced by single i.p. injection of 50 mg/ kg body weight streptozotocin (STZ) in 10mM citrate buffer pH 4.5. Animals were considered diabetic when the fasting blood glucose levels were > 250 mg/dl.
Group III (Atorvastatin-treared group): included 10 diabetic rats, each one of them received 1 ml atorvastatin (Lipitor-Pfizer) suspended in 2% gum acacia orally in a dose of 10 mg/kg body weight/day for 8 weeks starting 24 hours after induction of DM.
Insulin was administered once a day subcutaneously for 8 weeks in a dose of 4U/kg in the two diabetic groups.
At the end of the experiment (after 8 weeks), all rats were fasted overnight.
They were etheranaesthetized and blood was collected from retro-orbital venous plexus and serum was separated. Serum glucose and cholesterol was estimated by enzymatic methods (Stanbio Laboratory Inc.,). Then rats were scarificed by decapitation, and the 2 testes from each rat were quickly removed, washed with ice-cold saline, and stored at -80 o C in 5 portions until analysis. C until assayed for testosterone. 50 μl of BHT (2, 6-Ditetra-butyl-p-cresol) in ethanol (10 mg/ml) was added to 1 ml homogenate of each sample to prevent auto-oxidation. Each sample was mixed with 2 ml ethanol to remove protein and denature enzymes. Then 2 ml hexane was added, and the tightly capped tube was vigorously vortexmixed for 2 min. After centrifugation at 2200 rpm for 5 min., the hexane organic supernatant was transferred to a small vial. Hexane extraction was repeated, and the combined extracts were evaporated to dryness. The residue was re-dissolved in isopropanol.
Biochemical analysis Xanthine oxidase (XO) activity:
CoQ10 quantification: HPLC separation of the sample solution was performed shortly after its reconstitution on a spherisorb RP 18 5 micro 220x4.6 mm (Brownlee column) with a mobile phase composed of isopropanol-methanoltetrahydrofuran in the ratio of 55: 39: 
RESULTS
In table I, testicular levels of oxidants as presented by XO and NADPH oxidase activities as well as ROS levels showed significant higher levels in the non-treated diabetic rats (p < 0.0001). Atorvastatin administration to diabetic rats could decrease their levels when compared to non-treated diabetics (p< 0.0001, p< 0.001 and p< 0.0001 respectively). However, maximal protective effect of atorvastatin was evident with XO activity.
Results of testicular antioxidants were shown in table II. HO-1was increased significantly either in nontreated or atorvastatin-treated diabetic rats (p < 0.0001). CoQ10 levels decreased significantly in the nontreated diabetic group (p < 0.0001). Atorvastatin administration could improve CoQ10 levels to be nearly similar to normal control.
Testosterone in the testes of nontreated diabetic rats did not differ significantly from that of control ones (p> 0.05). However, atorvastatin elevated testosterone levels as compared to both control and nontreated diabetic groups (p < 0.05)( Table II) . Table III shows that serum glucose and cholesterol levels increase significantly in the STZ-induced diabetic groups (p < 0.0001, p < 0.001 respectively). Atorvastatin administration decreased cholesterol level significantly (p < 0.05) in the diabetic rats but failed to decrease their glucose concentration.
Correlation studies revealed that values for XO, NADPH oxidase, ROS, HO-1 and glucose showed direct correlation with each other (p < 0.01 except for XO with glucose where p < 0.05). In contrast, CoQ10 was only inversely correlated to the previously mentioned parameters (p < 0.01). Testosterone was only directly correlated to HO-1 (p < 0.01) (Table  IV) . 
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Correlation coefficient (r) values. ‫٭‬ significant at p < 0.05 (2-tailed) , ‫٭٭‬significant at p < 0.01 (2-tailed). ROS(reactive oxygen species) , HO-1(hemeoxygenase-1) , CoQ10(coenzyme Q10) .
DISCUSSION
Among various enzymes known to generate ROS, xanthine oxidase has been documented as an important biological source to produce O - which plays central role in the development of diabetic complications (4) . In the present study the experimental diabetes induced by STZ in male albino rats, had caused a significant increase in the XO activity in the rat's testicular homogenates as compared with that assayed in the control non-diabetic rats. The activity of XO could reflect the activity of testicular tissue to generate ROS and thus the occurred oxidative stress could play a fundamental role in the changes that may occur in the testes as complications of diabetes.
This observation agreed with many previous reports in different diabetic rat tissues such as liver (7) and plasma (4) . Jin and his colleagues
reported that xanthine oxidase was released from the liver of diabetic rats but not from the control non-diabetics, and this release was not the result of nonspecific protein leakage from the liver as other hepatic enzymes were not detected, neither in the diabetic nor in the control rat groups. The finding of the present study agreed not only with results in experimental diabetes but also with that obtained from clinical studies, and this provides evidence for the possible contribution of the enzyme to oxidative stress and the pathophysiology of diabetes (27) . Treatment of the diabetic rats with atorvastatin in this study resulted in a significant inhibition of the activities of the testicular xanthine oxidase of these animals as compared with the testicular enzyme activities in the diabetics who did not receive this treatment protocol. Here, atorvastatin through the inhibition of the activity of the oxidant-generating enzyme; XO, could decrease the release of superoxide radicals and could provide a protective antioxidative effect to the testicular tissues against the enhanced diabetes induced-oxidative stress.
Bandoh et al (28) reported that fluvastatin decreased reactive oxygen species such as hydroxyl radicals and superoxide anions, generated by the Fenton reaction and by the XO system, respectively.
In the current study, the activity of the enzyme NADPH oxidase of the testes was estimated as a possible pathway to generate ROS especially superoxide radicals. A significant increase in NADPH oxidase activity in the testes of diabetic rats was observed as compared with those in the non-diabetic controls. In the nondiabetic testes, NADPH oxidase has a very low constitutive activity that can be up-regulated in response to STZinduced hyperglycemia. This may contribute to the diabetic oxidative stress in the testis that may share in occurrence of testicular changes in diabetics.
These In the present study, when the diabetic rats were treated with atorvastatin, their testicular NADPH oxidase activity was significantly reduced. However, their levels did not return to the non-diabetic control values. So, atorvastatin could partially reverse the diabetic-induced oxidative stress. It seems likely that the antioxidant actions of statins are manifested via a variety of mechanisms and is at least partially due to inhibition of the activity of the enzyme NADPH oxidase, a major oxidant-generating enzyme in diabetes.
These findings were in agreement with many previous studies (33,34) . Wagner et al (34) reported that although HMG-CoA reductase inhibitors did not have a direct antioxidative effect, they effectively inhibited endothelial O - formation by preventing the isoprenylation of p21 rac, which is critical for the assembly of NADPH oxidase after activation of protein kinase C.
The streptozotocin-induced diabetics were associated with significant augmentation of the intensities of the DCF fluorescence as compared with that obtained from the control non-diabetics. As mentioned previously in this study, significant increase in the activity of the 2 major enzymes known in the pathways of the production of ROS; XO and NADPH oxidase, were detected in the testicular homogenates of the diabetic rats as compared with their activities in the testes from the non-diabetics. Diabetic status was associated with increased production of ROS, which in turn may be involved as a pathogenic mechanism for diabetic testicular complications.
These results were in agreement with many previously reported studies (35,36) . Satoh et al (35) reported that the DCF fluorescence in isolated glomeruli from diabetic rats was strong, indicating excessive O - production. They suggested that NAD(P)H-dependent oxidase and nitric oxide synthetase but not XO, are the predominant sources of superoxide radicals in the glomeruli of diabetic rats.
Administration of atorvastatin to the diabetic rats of the present study resulted in a significant reduction in the intensity of the fluorescence of the dye emitted from their testicular homogenates. Treating the diabetic rats with atrovastatin succeeded to decrease the release of ROS in their testes significantly. This effect was probably mediated through the detected inhibition of the activity of the enzymes; XO and NADPH oxidase.
Atrovastatin provided antioxidant protective function to the testes in diabetic rats. However, their levels did not return to the nondiabetic control values; atorvastatin could partially reverse the diabeticinduced oxidative stress.
The present study confirmed a previous in vitro and in vivo study in rats (37) . They found that exposure of cultured aortic endothelial cells and smooth muscle cells to a high glucose level significantly increased oxidative stress, as evaluated by the staining with 2', 7'-DCFH-DA measurement. This increase was completely blocked by the treatment with pitavastatin which could attenuate the increased oxidative stress in STZ-diabetic rats through inhibition of vascular NADPH oxidase. The significant positive correlation observed between the activities of XO & NADPH oxidase and DCF levels indicated that XO and NADPH oxidase may be major ROSproducing enzymes in the testes and the improvement in the oxidative stress induced by atorvastatin may be associated with their decreased activities. These data may suggest a possible antioxidant role of atorvastatin in testes.
In the present study, administration of atorvastatin to diabetic rats could significantly reduce the activities of XO and NADPH oxidase together with concomitant reduction in the testicular ROS contents.
However, the best improvement in oxidative stress was more apparent at the level of XO activity; atrovastatin could reverse the diabetic-induced oxidative stress changes for XO activity with only partial attenuation of NADPH oxidase and ROS levels in testis of the studied rats.
Hemeoxygenase-1(HO-1) as inducible enzyme can monitor the changes that may occur in the testes of either STZ-induced diabetic rats or atorvastatin-treated diabetics. In the present study, HO-1 levels were significantly increased in the testes of the diabetic rats as compared to control non-diabetics. In response to the increase in the production of oxidants that was detected in the testicular homogenates of the present studied diabetic rats, the endogenous testicular antioxidant enzyme HO demonstrated increased oxidative stress measured by increased 8-hydroxydeoxy guanosine in association with increased HO1expression and activity in heart of STZ-induced diabetic rats. However, in non-diabetic rats, they found similar changes like those in diabetics after hemin (HO agonist) administration, thus suggesting a prooxidant activity of HO in heart.
The present data provided an evidence of increased HO-1 levels of STZ-induced diabetic testes; however the exact mechanism of its action needs further investigations.
The administration of atorvastatin to the diabetic rats of the present study did not cause any significant change in testicular HO-1 level, which denied an effect of atorvastatin on HO-1 in testis of diabetic rats. Despite extensive studies on the molecular mechanisms of statins, it remained unclear whether HO-1 was preferentially related to the cytoprotective effects of statins.
Lee et al (45) found that simvastatin could not induce HO-1 either in aortic endothelial cells and macrophages in vitro culture or in vivo after 5 mg/kg i.p. injection in mesenchymal cells of lungs and kidneys. However, simvastatin preferentially induced HO-1 in hepatocytes and arterial vascular smooth muscle cells. In addition, statins could increase HO-1 expression, but not activity, in liver and brain of mice (46) . So, the HO-1 induction by statin seems to be tissuespecific without any role in testes of diabetic rats. reported that in the Goto-Kakizaki diabetic rat model, testicular mitochondria were less susceptible to oxidative stress due to increase in the antioxidants; GSH and CoQ9. This represented an adaptive response in this animal model. Salardi et al (50) found that there was no change in the blood reactive oxygen metabolites, vitamin E, and coenzyme Q10 levels of diabetic patients from age-matched control subjects. Coenzyme Q10 values were higher in patients with poor control than in those with good control of diabetes.
As coenzyme Q shares a common biosynthetic pathway with cholesterol, so the inhibitors of HMG-CoA reductase as atorvastatin could also inhibit the CoQ biosynthesis. However, it is not usually the case. In a previous study Sprague-Dawley rats responded to simvastatin treatment for 2 weeks by a marked increase in lens cholesterol synthesis (51) . Thus, statins can have prounced effects on cells independent of inhibiting cholesterol biosynthesis; as an antioxidant (13) and an anti-inflammatory (52) agents. When diabetic rats, of the present study, received atorvastatin, CoQ10 contents of their testes were significantly higher compared to nontreated diabetics. This increase could reflect the drug-induced improvement in oxidative stress rather than the cholesterol synthesis-inhibition pathway. Although studies have repeatedly demonstrated either a reduction (53) or no effect (54) of statin therapy on circulating CoQ10 concentrations, it is unclear as to whether tissue levels of CoQ10 were significantly affected. As an example, muscle CoQ10 concentration did not differ significantly between the statinrelated myopathy patients and control subjects (55) . However, studies regarding the effect of statin on CoQ10 levels in diabetic testes are not available to compare with.
The testicular testosterone level was measured to evaluate the endocrine function of the Leydig cells. In the current study, non-significant change in the testicular testosterone levels was detected in the STZinduced diabetic rats as compared with that in the control non-diabetics. Thus, diabetes did not alter the steroidogenic function of testes.
Although, the increase in the oxidant production was detected in the testes of diabetic rats, but this was accompanied by enhancement of the activity of the endogenous antioxidant enzyme; HO-1. This provided some sort of endogenous protection to these testes against oxidative damage. The positive significant correlation between testosterone and HO-1 supported this suggestion.
The present finding was confirmed by Komaki et al (56) . They reported that although, there was no significant difference in serum levels of free testosterone between the male OLETF diabetic rats, a model of human type-2 diabetes, and the control LETO rats, the histological studies of their testes revealed atrophy of seminiferous tubules. Therefore, it would seem that the hypogonadism of diabetic rats may develop primarily in the form of testicular atrophy associated with decline in sperm count without change of interstitial tissue function and the circulating sex hormone.
In contrast, some researchers demonstrated a decrease in plasma and testicular testosterone levels together with decreased androgen receptor expression in diabetic rats (57) . When the diabetic rats received atrovastatin for 8 weeks in this study, the testicular testosterone level was significantly elevated as compared with the diabetic animals who did not receive the treatment. This observation was actually in contrast of the fact that statins cause reduction in plasma cholesterol. As cholesterol is a precursor of steroid hormones, so inhibition of cholesterol biosynthesis can, in theory, adversely affect testicular secretion of testosterone either by decreasing the supply of the cholesterol to testes or by inhibiting in situ cholesterol synthesis (58) . Moreover, the poor bioavailability of statin in peripheral tissues, as testes, may not reflect the effects the agents are having in liver.
In this study, atorvastatin was found to have many effects against the occurrence of oxidative stress in the testes of diabetics; through inhibition of oxidants production together with enhancement of endogenous antioxidants. Atorvastatin actually could protect the testes of the diabetic rats against the enhanced oxidative damage; thus could cause an enhancement of testicular synthesis of the sex hormones.
Many previous studies demonstrated that the treatment of statins had no impact on steroidogenesis either in non-diabetic subjects (14,58) and rats (59) or in diabetic patients (60) in spite of their significant effects on lowering total and LDLcholesterol levels.These results were cosistent with that of the present study.
Andreis et al (61) reported that with prolonged lovastatin administration, Leydig cells progressively recovered their secretory activity due to a striking proliferation of smooth endoplasmic reticulum and peroxisomes, aimed at maintaining an adequate production of cholesterol (i.e. testosterone precursors) in spite of the chronic competitive inhibition of its synthesis through inhibition of HMG-CoA reductase enzyme.
Glycemic levels in all rats of this study showed direct correlation with ROS-producing enzymes and ROS levels and inverse correlation with antioxidant CoQ10 levels. These data point to the link between hyperglycemia and oxidative stress in testes. However the exact mechanisms of this stress in diabetes mellitus are not fully understood , hyperglycemia, polyol activation and glycation end products may share in ROS synthesis (3) . Atorvastatin administration could not modulate STZ-induced hyperglycemia in the diabetic rats of this study which are confirmed by some investigators
(13).
The present data, collectively, could provide an evidence of oxidative stress in testes of STZinduced diabetic rats. Atorvastatin administration could attenuate this stress not only by decreasing ROSproducing enzyme activities and ROS levels but also by improving the antioxidant CoQ10 levels. Thus, atorvastatin can act through cholesterol-dependant and -independent antioxidant mechanisms but without any apparent effect on hyperglycemia or HO-1 modulation. 
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